Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FYM47
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,966
Award facts
- Contract value 100% obligated
- $32,966.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 30 tablets of Cabometyx 40 mg. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, was awarded without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the Department of Defense pharmaceutical supply chain, delivering a comprehensive range of medications including branded and generic prescription drugs, biologics, vaccines, and specialty pharmaceuticals to military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. The PPV-G GEN V program represents part of the broader $30.3 billion federal pharmaceutical acquisition strategy designed to support recurring medical supply needs of Department of Defense healthcare operations globally, with DMS Pharmaceutical Group positioned as one of multiple regional prime vendor contractors within this strategic framework.
Quick answers
Who was awarded contract SPE2DB26FYM47?
SPE2DB26FYM47 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FYM47 worth?
The government has obligated $32,966 on SPE2DB26FYM47.
Is contract SPE2DB26FYM47 an order under another contract?
Yes. SPE2DB26FYM47 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM47 competed?
The extent of competition for SPE2DB26FYM47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award